01. Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities.
02. Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
03. Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis.
04. Daratumumab monotherapy for refractory lupus nephritis.